top of page

BackTable / Urology / Contributor

Dr. Aditya Bagrodia on the BackTable Urology Podcast

Dr. Aditya Bagrodia

Genioturinary Oncologist

Dr. Aditya Bagrodia is an associate professor of urology and genitourinary oncology team leader at UC San Diego Health in California and adjunct professor of urology at UT Southwestern.

Listen to Dr. Aditya Bagrodia on the BackTable Urology Podcast

The BackTable Podcast is a knowledge resource by physicians for physicians. Learn from the experiences and expertise of Dr. Aditya Bagrodia and get practical advice on how to build your practice by listening to the BackTable Urology Podcast.

Ep 177 Latest Approaches to Treat High-Risk NMIBC with Dr. Ashish Kamat
00:00 / 01:04

Stay Up To Date



Sign Up:

About Dr. Aditya Bagrodia

Aditya Bagrodia, M.D., is an associate professor of urology and genitourinary oncology team leader at UC San Diego Health in California and adjunct professor of urology at UT Southwestern.

Dr. Bagrodia holds a bachelor of science degree from Rhodes College. While earning a medical degree with highest honors at the University of Tennessee Health Sciences Center, he was awarded a Doris Duke Clinical Research Fellowship at UT Southwestern Medical Center.

After completing his residency in urology at UT Southwestern, he received advanced training in urologic oncology through a fellowship at Memorial Sloan Kettering Cancer Center, where he was awarded a Urology Care Foundation Research Scholars Grant by the American Urological Association.

Dr. Bagrodia’s clinical practice focuses on treating all urologic malignancies, including adrenal, upper tract, renal, bladder, prostate, penile, and testicular cancers. He has expertise in complex multidisciplinary management and minimally invasive approaches to urologic surgery.

Dr. Bagrodia has conducted extensive research in urologic oncology, primarily in biomarker profiles and molecular signatures of urologic tumors as predictors of clinical outcomes. He is funded through competitive grants from the Cancer Prevention and Research Institute of Texas (CPRIT), intramural research grants, and the National Institutes of Health.

Both his clinical practice and research centers on patients with germ cell tumors (most commonly testicular cancer). His laboratory focuses on sequencing efforts to understand tumor evolution and heterogeneity in germ cell tumors and identifying novel biomarkers to recognize occult metastatic disease. The Bagrodia lab also conducts experiments in cell lines, zebrafish germ cell tumor models, and mice to understand the biologic implications of genetic alterations that are seen exclusively among patients with cisplatin-resistance disease. He is actively working on molecular biomarkers to identify minimal residual disease burden. On the clinical side, Dr. Bagrodia is actively involved in understanding and overcoming unique socioepidemiologic considerations that adversely impact oncologic outcomes in patients with germ cell tumors. He is also the principal investigator for several germ cell tumor-directed clinical trials at UT Southwestern (including NCT03426865 and NCT02537548).

Dr. Bagrodia is the principal author or co-author of more than 100 articles in peer-reviewed publications such as Journal of Clinical Oncology, Nature Genetics, European Urology, Journal of Urology, Urologic Oncology, and Urology. He is also a reviewer for many of these publications, as well as for the British Journal of Urology, Journal of Clinical Pathology, and Annals of Surgical Oncology.

Learn more by visiting Dr. Aditya Bagrodia's practice:

Podcasts Featuring Dr. Aditya Bagrodia

Episode #177


Dr. Ashish Kamat discusses contemporary management of high-risk, non-muscle-invasive bladder cancer (NMIBC) and his thoughts into the future of this arena.

Episode #176


Dr. Charla Holdren, a resident at the University of Michigan-West, and Dr. Christine Van Horn, an endourology fellow at Loyola, explore the high rates of infertility and pregnancy complications among female urologists.

Episode #173


Dr. Aditya Bagrodia sits down with Elie Toubiana, founder and CEO of, to discuss the transformative potential of artificial intelligence (AI) in medical documentation.

Episode #171


In this episode of Back Table Urology, Dr. Aditya Bagrodia, Dr. Joshua Langston, and Dr. Mara Holton from the Large Urology Group Practice Association (LUGPA) share insights on the financial and administrative complexities that urologists face.

Episode #170


In this episode of BackTable Urology, host Dr. Aditya Bagrodia, urologic oncologist Dr. Philippe Speiss (Moffitt Cancer Center), and medical oncologist Dr. Andrea Necchi (Università Vita-Salute San Raffaele) have an in-depth discussion about the mission and achievements of the Global Society of Rare Genitourinary Tumors (GSRGT).

Episode #169


In this episode, Dr. Matthew Cooperberg (UC San Francisco) and Dr. Arvin George (Johns Hopkins) join host Dr. Aditya Bagrodia in a conversation about guidelines and treatment algorithms for focal therapy in prostate cancer treatment.

Episode #165


In this episode of BackTable Urology, Dr. Aditya Bagrodia invites Dr. Andrew Harris (University of Kentucky) to discuss the significance of quality improvement using the lean methodology to improve patient safety and healthcare efficiency.

Episode #160


This week on BackTable Urology, Dr. Seth Lerner (Baylor College of Medicine) discusses the intricacies of lymph node dissection in bladder cancer management, including an overview of patterns of metastasis, genomic classifiers, and recent clinical trials.

Episode #159


This week on BackTable Urology, Dr. Aditya Bagrodia speaks with Dr. Ganesh Palapattu, Chair of Urology at the University of Michigan about the evolving role of a surgeon scientist, the balance between clinical work and research, and the importance of mentorship and positivity.

Episode #157


In this special crossover episode with the Bladder Cancer Matters podcasts, Rick Bangs, a bladder cancer survivor, and Dr. Aditya Bagrodia, a urologic oncologist, discuss shared decision-making in bladder cancer treatment.

Episode #155


In this episode of BackTable Urology, Dr. James Eastham, chief of urology at Memorial Sloan Kettering Cancer Center, discusses evolving approaches and treatments in prostate cancer.

Episode #154


In this episode of BackTable Urology, Dr. Aditya Begrodia interviews Dr. Mara Holton, a urologist and healthcare policy expert, on the recent healthcare policy changes that have affected the field of urology.

Episode #153


In this episode, Dr. Edward Schaeffer, chair of urology at Feinberg School of Medicine, discusses precision medicine in prostate cancer with Dr. Aditya Bagrodia.

Episode #151


This week on BackTable Urology, Dr. Aditya Bagrodia invites Dr. Stacy Loeb, Professor of Urology at NYU Grossman School of Medicine, to discuss the role of lifestyle medicine in prostate cancer prevention.

Episode #150


In this episode, host Dr. Aditya Bagrodia speaks with guests Dr. C.J. Stimson and Dr. Ruchika Talwar from Vanderbilt University about the relationship between physicians and big business in modern healthcare.

Episode #145


In this episode, Dr. Aditya Bagrodia (UC San Diego), Dr. Lindsay Hampson (UC San Francisco) and Dr. Gina Badalato (Columbia University) discuss the lasting impact of the COVID-19 pandemic on urology education.

Episode #139


In this week’s BackTable Podcast, guests Dr. Sarah Psutka and Dr. Rachel Rubin join host Dr. Aditya Bagrodia to discuss the importance of considering women’s sexual health in urologic oncology surgeries.

Episode #135


This week on BackTable Urology, Dr. Aditya Bagrodia (UC San Diego), Dr. Clint Cary (Indiana University), and Dr. Gagan Prakash (Tata Memorial Hospital) discuss the diagnosis and management of metastatic testicular cancer.

Episode #134


In this episode of BackTable Urology, Dr. Aditya Bagrodia and Dr. Christopher Anderson (Columbia University) discuss the diagnosis and workup of kidney cancer, including renal biopsy techniques.

Episode #128


This week on BackTable Urology, urologists Dr. Aditya Bagrodia (UC San Diego) and Dr. Giovanni Cacciamani, assistant professor of urology at the University of Southern California, discuss how artificial intelligence can improve urology practice and research.

Episode #126


This week on BackTable Urology, Dr. Aditya Bagrodia (UCSD), medical oncologist Dr. Rana McKay (UCSD) and radiation oncologist Dr. Shankar Siva (University of Melbourne) discuss the growing role of radiation therapy in kidney cancer treatment.

Episode #119


In this episode of BackTable Urology, Dr. Bagrodia interviews Dr. Peter Scandino, world-renowned urologist and professor emeritus of urology at Memorial Sloan Kettering Cancer Center (MSK), about his journey to becoming a urologist and life lessons he has learned along the way.

Episode #115


This week on BackTable Urology, Dr. Aditya Bagrodia and Dr. Dharam Kaushik, a urologic oncologist from Houston Methodist Hospital, discuss the impact of yoga on their lives in preventing burnout and encouraging compassion.

Episode #114


This week on the BackTable Urology Podcast, Dr. Jose Silva discusses sexual health with Dr. Arthur “Bud” Burnett, professor of urology at John Hopkins University, with an emphasis on the importance of preventative medicine in improving sexual health and different treatments for erectile dysfunction.

Articles Featuring Dr. Aditya Bagrodia

The Modern Role of Genomics & Imaging in Prostate Cancer Diagnosis & Treatment

Advancements in genomics and imaging are transforming prostate cancer diagnosis and treatment by reducing overdiagnosis and personalizing treatment. Learn more about the integration of genomic tests and imaging techniques to help distinguish between benign conditions and clinically significant cancers.

Active Surveillance for Prostate Cancer: A Tailored Approach

When prostate cancer is at low risk of progression, active surveillance is often the preferred management approach to avoid treatment side effects. Urologic oncologists Dr. Aditya Bagrodia and Dr. Ashley Ross walk through contemporary strategies for prostate cancer surveillance.

High-Risk Prostate Cancer: Diagnosis & Treatment Strategies

Radical therapy remains the cornerstone in the treatment of high-risk prostate cancer, encompassing modalities such as radical prostatectomy and brachytherapy. Criteria for the high-risk prostate cancer designation typically include a Gleason score ranging from 8 to 10, grade 4 or 5, or PSA levels surpassing 20.

Radiation Therapy for High-Risk Prostate Cancer: Which Modality is Best?

Urologic oncologist Dr. Aditya Bagrodia and radiation oncologist Dr. Daniel Spratt explain their approach to radiation therapy in high-risk prostate cancer treatment, emphasizing the latest clinical evidence.

Transperineal Prostate Biopsy: A Practical Guide to Procedural Success

This practical guide walks urologists through how to perform the transperineal prostate biopsy procedure. Key concepts for beginning physicians include unlearning transrectal biopsy habits and becoming proficient in the freehand technique to enhance precision.

Which Is Better: Transrectal or Transperineal Prostate Biopsy?

Which is better, transrectal or transperineal prostate biopsy? Three leading urologists discuss prostate biopsy procedures, considering safety, cancer detection rates, and more!

Transperineal Prostate Biopsy Tools, Equipment & Instruments

Urologists Aditya Bagrodia, Matt Allaway, and Juan Javier-DesLoges explore the role of various equipment, tools, and instruments in switching from a traditional transrectal biopsy to the more efficient transperineal biopsy approach.

TULSA prostate treatment device

TULSA prostate treatment is a new prostate cancer treatment option that uses real-time MRI thermometry to visualize treatment areas and boundaries. TULSA treatment for prostate cancer requires proper patient selection and preparation are crucial for success. Learn more!

Tulsa procedure technique device placement diagram

The TULSA procedure for the treatment of prostate cancer involves several technical steps, including imaging, device placement, ablation control, & real-time monitoring. Learn more in this guide.

Transurethral ultrasound ablation MRI

Transurethral ultrasound ablation may offer distinct advantages over alternative treatment options for prostate cancer. Xioasong Meng and Dr. Aditya Bagrodia team up with radiologist Dr. Daniel Costa to explain how to establish a TULSA program for prostate cancer treatment.

Histology of high grade bladder cancer

The management of high-grade BCG-unresponsive bladder cancer begins with the establishment of cytology and, based on the patient profile, is followed by either TURBT or total cystectomy. Alternatives to BCG for bladder cancer are available, but ongoing research continues to explore other options.

Cystoscopic Image of Bladder cancer

BCG-unresponsive bladder cancer has distinct criteria for diagnosis and management. Official FDA diagnosis requires the development or recurrence of a high-grade bladder tumor after a patient has received adequate BCG therapy. Treatment duration varies based on whether an induction or maintenance course is indicated.

Doctor holding cystoscope for TURBT procedure

The TURBT procedure for bladder cancer is a common procedure. Urologist Dr. Chang shares his approach to successful bladder cancer resection with TURBT, covering his technique before, during, & after.

Testicular pain treatment consultation between physician and patient

Upper tract urothelial carcinoma is a rare entity with a lack of prospective data to guide clinical decisions. Dr. Shariat, who led the charge on building multicenter data sets for the condition, joins Dr. Bagrodia to discuss surgical management.

Doctor demonstrating prostate anatomy for potential radiotherapy complications

Urologists commonly utilize radiotherapy in the treatment of prostate cancer, but like most treatment modalities, it is not without its complications. Learn more about specific complications and the role of patient-specific and prostate-specific factors in determining candidacy for treatment. 

Male patient undergoing external radiation therapy

Internal radiation therapy and external radiation therapy are often used by Urologists in the treatment of prostate cancer. Understanding the differences between the two forms of radiation is pertinent for deciding the patient's treatment plan.

A transgender individual receiving a pelvic exam to evaluate for bottom surgery.

Many transgender individuals undergo gender affirming pelvic surgery, or bottom surgery. This article discusses common bottom surgery complications and their management.

A transgender woman talks to her doctor about gender affirming surgery

Transgender and gender diverse patients often seek urological care when they are interested in gender affirming surgery. This article discusses terminology and gender affirming surgery options available to transgender patients.

Blue light cystoscopy screening for bladder cancer recurrence

Blue light cystoscopy is useful in managing bladder cancer, both for complete tumor resection in the OR and as routine surveillance office cystoscopy to monitor bladder cancer recurrence.

Man being treated with radiation for prostate cancer.

When deciding on prostate cancer surgery vs radiation, it is important to know all of the pros and cons. They can both be effective treatments for prostate cancer, but you should be informed of the risks based on your age. This article covers both prostate cancer treatments.

A doctor consulting a patient about prostate cancer.

This article discusses the criteria to start prostate cancer active surveillance, various modalities to monitor disease progression, and indications to initiate other treatment.

A backtable set up for a ureteroscopy

A ureteroscopy should be performed if a stone fails trial of passage. This article breaks down the peri-operative and post-op care, as well as technique for this procedure.

Patient with a secured nephrostomy tube from treatment of obstructive pyelonephritis

Obstructive pyelonephritis can present as an emergency, and must be correctly identified and treated. This article discusses the diagnosis and treatment of this condition, along with medical management of a trial of passage.

Kidney cancer surgery, specifically, a nephrectomy

Kidney cancer surgery can be aggressive or conservative, depending on various factors. This article discusses when to perform a partial vs. radical nephrectomy, the indications for lymph node dissection, and the viability of a robotic approach.

Get Connected

Thank you for listening! If you have a question for Dr. Aditya Bagrodia about a topic discussed on the BackTable Urology Podcast, you can get in touch with this form. Please note that our contributors are not able to respond to every inquiry.

Select which show(s) you would like to subscribe to:

Thanks! Message sent.

Disclaimer: The Materials available on are for informational and educational purposes only and are not a substitute for the professional judgment of a healthcare professional in diagnosing and treating patients. The opinions expressed by participants of the BackTable Podcast belong solely to the participants, and do not necessarily reflect the views of BackTable.



Latest Approaches to Treat High-Risk NMIBC with Dr. Ashish Kamat on the BackTable Urology Podcast)
Family Planning for Female Urologists: Facts & Figures with Dr. Christine Van Horn and Dr. Charla Holdren on the BackTable Urology Podcast)
AI Scribes: Enhancing Patient & Physician Interaction with Elie Toubiana on the BackTable Urology Podcast)
Rethinking Healthcare Administration & Policy with Dr. Mara Holton and Dr. Josh Langston on the BackTable Urology Podcast)
GSRGT: Collaborative Approaches to Rare GU Oncology with Dr. Philippe Spiess and Dr. Andrea Necchi on the BackTable Urology Podcast)
Perfecting Rectal Spacer Placement for Optimal Care with Dr. Neil Taunk on the BackTable Urology Podcast)


Artifical Urinary Sphincter (AUS) Surgery Procedure Prep
Bipolar Transurethral Resection of the Prostate (TURP) Procedure Prep
Bladder Cancer Condition Overview
Cystoscopy Procedure Prep
Pelvic Floor Therapy Procedure Prep
Penectomy Procedure Prep

More Contributors

Dr. Neeraj Agarwal on the BackTable Urology Podcast

Dr. Neeraj Agarwal

Rick Bangs on the BackTable Urology Podcast

Rick Bangs

Dr. Sam Chang on the BackTable Urology Podcast

Dr. Sam Chang

Dr. Timothy Clinton on the BackTable Urology Podcast

Dr. Timothy Clinton

Dr. Suzanne Cole on the BackTable Urology Podcast

Dr. Suzanne Cole

Dr. Siamak Daneshmand on the BackTable Urology Podcast

Dr. Siamak Daneshmand

bottom of page